NCT00802425View on ClinicalTrials.gov

Efficacy of AM-111 in Patients With Acute Sensorineural Hearing Loss

PHASE2CompletedINTERVENTIONAL

Enrollment

210

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

July 31, 2012

Study Completion Date

October 31, 2012

Conditions

Hearing Loss

Interventions

DRUG

AM-111

single intratympanic injection

DRUG

placebo

single intratympanic injection

Trial Locations (1)

81366

LMU Munich Klinikum Grosshadern, Munich

Sponsors

Lead Sponsor

Auris Medical AG

All Listed Sponsors

lead

Auris Medical AG

INDUSTRY

NCT00802425 - Efficacy of AM-111 in Patients With Acute Sensorineural Hearing Loss | Biotech Hunter | Biotech Hunter